Microba secures $14.5 million to drive clinical adoption
Filed with ASX · · 11 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallMicroba Life Sciences Limited on 6ix
In the deck
Earlier from Microba Life Sciences
- Suspension from Quotation
- Trading Halt
- MetaPanel Pathogen Study Delivers Breakthrough Results
- Microba Announces Landmark GI Study Results From Over 4,600 Patients
- Landmark GI Study Results from over 4,600 patients
Later from Microba Life Sciences
- Disclosure Document - Prospectus
- Q4 FY25 Quarterly Activities Report & Appendix 4C
- Q4 FY25 Quarterly Investor Presentation & Webinar
- 2025 Annual Report & Appendix 4E
- Q1 FY26 Quarterly Activities Report & Appendix 4C
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences